The Master of Science (M.Sc.) in Bioprocess Engineering is delivered by DCU's School of Biotechnology in conjunction with TCD School of Pharmacy and Pharmaceutical Sciences and the National Institute for Bioprocessing Research and Training (NIBRT). It is accredited by DCU.
The M.Sc. is an interactive and dynamic programme that will develop your knowledge and appreciation of the conceptual and factual bases for bioprocess design and operation. It also develops your understanding of bioprocessing, particularly the structures, roles and experimental methods associated with biopharmaceuticals, their analysis, production methods and technology for monitoring and control of bioprocesses.
It provides an advanced and up-to-date academic base in the major disciplines of bioprocess engineering and fosters a range of transferable skills across a full range of relevant subjects.
To update and upgrade the knowledge, understanding and skills of graduates who are interested in pursuing or are currently working in the Biopharmaceutical industry. To retrain graduates working in related disciplines, by providing advanced level modules in the theory, analysis design and practical methodology of the rapidly evolving subjects that are associated with this sector.
The programme has an excellent reputation in the biopharmaceutical industry, with a number of companies (Eli Lilly, Pfizer, Merck, BMS) registering employees for the full or partial programme.
This post-graduate programme builds on the world-renowned experience of the course presenters, including professors, lecturers and industrial experts.
The programme provides a platform for entry into research-level positions (PhD, further specialised programmes) and industries involved in the production of recombinant therapeutic proteins/diagnostics.
It also provides a highly interactive environment for the understanding of real bioprocesses, and to encourage discussion with industry experts in a dynamic environment, on actual problems and challenges in the bioprocessing sector.